Follow
Adrian Villalba
Adrian Villalba
Postdoctoral Researcher, Institut Cochin, Paris
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry
S Rodriguez-Fernandez, I Pujol-Autonell, F Brianso, D Perna-Barrull, ...
Frontiers in immunology 9, 314289, 2018
652018
Strong artificial selection in domestic mammals did not result in an increased recombination rate
V Muñoz-Fuentes, M Marcet-Ortega, G Alkorta-Aranburu, ...
Molecular biology and evolution 32 (2), 510-523, 2015
442015
Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes
A Villalba, S Rodriguez-Fernandez, RM Ampudia, M Cano-Sarabia, ...
Artificial Cells, Nanomedicine, and Biotechnology 48 (1), 77-83, 2020
222020
NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes
L Gomez-Muñoz, D Perna-Barrull, A Villalba, S Rodriguez-Fernandez, ...
Frontiers in immunology 11, 611522, 2021
202021
Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study
A Villalba, M Fonolleda, M Murillo, S Rodriguez-Fernandez, RM Ampudia, ...
Translational Research 210, 8-25, 2019
202019
Repurposed analog of GLP-1 ameliorates hyperglycemia in type 1 diabetic mice through pancreatic cell reprogramming
A Villalba, S Rodriguez-Fernandez, D Perna-Barrull, RM Ampudia, ...
Frontiers in Endocrinology 11, 258, 2020
192020
Impaired phagocytosis in dendritic cells from pediatric patients with type 1 diabetes does not hamper their tolerogenic potential
S Rodriguez-Fernandez, M Murillo, A Villalba, D Perna-Barrull, ...
Frontiers in immunology 10, 494483, 2019
132019
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes
A Villalba, S Rodriguez-Fernandez, D Perna-Barrull, RM Ampudia, ...
Scientific reports 10 (1), 18927, 2020
72020
Prenatal betamethasone interferes with immune system development and alters target cells in autoimmune diabetes
D Perna-Barrull, S Rodriguez-Fernandez, I Pujol-Autonell, A Gieras, ...
Scientific reports 9 (1), 1235, 2019
62019
Synthetic embryos: a new venue in ethical research
A Villalba, J Rueda, Í de Miguel Beriain
Reproduction 165 (4), V1-V3, 2023
42023
Re-defining the human embryo: A legal perspective on the creation of embryos in research
I De Miguel Beriain, J Rueda, A Villalba
EMBO reports, 1-4, 2024
12024
The ethics of cellular reprogramming
A Smajdor, A Villalba
Cellular Reprogramming 25 (5), 190-194, 2023
12023
A letter to the article “Whole Body Gestational Donation” published by Anna Smajdor in Theoretical Medicine and Bioethics
G Díaz-Cobacho, A Villalba
Theoretical Medicine and Bioethics 44 (4), 375-378, 2023
12023
Human stem-cell-derived embryo models: When bioethical normativity meets biological ontology
A Villalba, J Rueda, Í de Miguel Beriain
Developmental Biology 508, 88-92, 2024
2024
Queering the genome: ethical challenges of epigenome editing in same-sex reproduction
A Villalba
Journal of Medical Ethics, 2024
2024
A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation.
A Villalba, Y Gitton, M Inoue, V Aiello, R Blain, M Toupin, ...
2023
Pancreatic Islet Cells Response to IFNγ Relies on Their Spatial Location within an Islet
M De Burghgrave, C Lourenço, C Berthault, V Aiello, A Villalba, A Fouque, ...
Cells 12 (1), 113, 2022
2022
Proposal of a novel method of oocyte activation to derive human parthenogenetic stem cells
A Villalba Felipe
2015
The system can't perform the operation now. Try again later.
Articles 1–18